Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 71 | 21 | 0 | 0 | 0 |
| Cost of Goods | 26 | 11 | N/A | N/A | N/A |
| Gross Profit | 46 | 10 | N/A | N/A | N/A |
| Operating Expenses | 648 | 663 | 1,164 | 857 | 993 |
| Operating Income | -577 | -642 | -1,164 | -857 | -993 |
| Interest Expense | 168 | 116 | 144 | 105 | 35 |
| Other Income | -2,039 | -321 | -830 | -78 | -2,469 |
| Pre-tax Income | -2,784 | -1,078 | -2,138 | -1,040 | -3,497 |
| Net Income Continuous | -2,784 | -1,078 | -2,138 | -1,040 | -3,497 |
| Net Income Discontinuous | N/A | -582 | -18 | N/A | N/A |
| Net Income | $-2,784 | $-1,660 | $-2,156 | $-1,040 | $-3,497 |
| EPS Basic Total Ops | -5,460.00 | -300.00 | -1,420.00 | -40.00 | -20.00 |
| EPS Basic Continuous Ops | -5,459.00 | -200.00 | -1,400.00 | -47.68 | -16.46 |
| EPS Basic Discontinuous Ops | N/A | -100.00 | -20.00 | N/A | N/A |
| EPS Diluted Total Ops | -5,460.00 | -300.00 | -1,420.00 | -40.00 | -20.00 |
| EPS Diluted Continuous Ops | -5,459.00 | -200.00 | -1,400.00 | -47.68 | -16.46 |
| EPS Diluted Discontinuous Ops | N/A | -100.00 | -20.00 | N/A | N/A |
| EBITDA(a) | $-563 | $-628 | $-1,115 | $-851 | $-376 |